Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
NCT Number: NCT05835154
This trial tests how well the advanced care planning around mobility needs checklist tool works to assess future mobility needs in patients with sarcoma. Gathering information about sarcoma patients that have had surgery to either save or remove a limb may help doctors learn more about a patient's mobility needs. Using an advance care planning mobility needs assessment may help improve the quality of life in patients with sarcoma by helping them plan for their future mobility needs.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Seattle, Washington, 98109, United States
OUTLINE:
FIELD TEST: Participants complete the advance care planning (ACP) Mobility Checklist on study. Participants complete questionnaires at baseline and after completing the checklist intervention and undergo interview on study. Participants' medical records are also reviewed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Complete checklist
Other names: Assess
Complete questionnaires
Undergo semi-structured feedback interview
Review of medical records
Time frame: At enrollment
The number of participants accrued during the recruitment period.
Time frame: Through study completion, up to 4 weeks
The number of participants to complete the intervention.
Time frame: After completion of intervention (+ 1 week)
The Acceptability E-Scale is a 6-item scale, scored on a 5-point Likert scale (e.g., 1=very difficult; 5= very easy), with previously demonstrated good internal consistency (Cronbach's alpha=.76), with higher values indicating higher levels of acceptability.
Time frame: After completion of intervention (+ 1 week)
Usability of the ACP Mobility Checklist will be assessed among patients using the System Usability Scale (SUS). The SUS is a 10-item scale, scored on a 5-point Likert scale (1=strongly disagree; 5=strongly agree), with higher values indicating higher levels of usability.
Time frame: After completion of intervention (+ 1 week)
Satisfaction with the intervention will be assessed with a single, 10-point Likert scale item assessing how satisfied participants are with the intervention (1= not at all satisfied, 10 = extremely satisfied). Higher values indicate higher ratings of satisfaction.
Time frame: From baseline to after completion of intervention (+ 1 week)
Will be measured by asking participants seven items about what mobility needs they have planned for (e.g., assistance with home environment, toileting, dressing, etc.) (yes/no). Total scores can range from 0 to 7, with higher values indicating higher rates of understanding and awareness.
Time frame: From baseline to after completion of intervention (+ 1 week)
Functional status will be measured using the PROMIS Cancer Function Brief, which is a validated 12-item scale scored on a 5-point Likert scale, with higher scores indicating better functioning.
Time frame: From baseline to after completion of intervention (+ 1 week)
Engagement in clinical conversations (present/absent) with providers will be measured with four questions asking patients if they have had an interaction or consult with a physical therapist, occupational therapist, speech language pathologist, and/or rehabilitation physician (yes/no). Total scores can range from 0 to 4, with higher values indicating higher rates of engagement in clinical conversations with specialist providers.
Time frame: From baseline to after completion of intervention (+ 1 week)
This will be measured using our previously utilized 8-item measure of discussing end-of-life care, living will, healthcare proxy, and do-not-resuscitate orders with family and doctor (all yes/no questions).
Time frame: From baseline to after completion of intervention (+ 1 week)
This will be assessed by asking patients whether they have completed a Do Not Resuscitate order (DNR), living will, or identified a Health Care Proxy (HCP). All yes/no questions.
Fred Hutchinson Cancer Center
Other
Improving Advance Care Planning Around Mobility Needs Among Patients With Sarcoma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01106872
Locally Advanced Sarcoma, Metastatic Sarcoma
Iowa City, Iowa, United States
View Trial DetailsNCT04457258
Metastatic Sarcoma, Neoplasms
Los Angeles, California, United States
View Trial DetailsNCT06298916
Colonic Diseases, Colorectal Cancer
Duarte, California, United States
View Trial DetailsNCT01112384
Metastatic Sarcoma, Neoplasms
Calgary, Alberta, Canada
View Trial Details